基本情報
- CAS
179248-59-0- 標準SMILES
COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC- InChIKey
DMWVGXGXHPOEPT-UHFFFAOYSA-N- 分子式
- C22H19N3O3
- 平均分子量
- 373.4 g/mol
- 単同位体質量
- 373.14264147
概要
Src Inhibitor-1 is a member of the class of quinazolines that is quinazoline which is substituted at position 4 by a p-phenoxyanilino group and at positions 6 and 7 by methoxy groups. It is a potent, competitive dual site (both the ATP- and peptide-binding) Src kinase inhibitor. Src Inhibitor-1 is one of the 'gold standards' for Src kinase inhibition that has been shown to use PP1 or PP2 in parallel with Src-I1 to inhbit Src family kinases. It has a role as an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor. It is an aromatic ether, a member of quinazolines, a polyether and a secondary amino compound.
名称と識別子
- 優先名称
- Src Kinase Inhibitor I
- IUPAC
- 6,7-dimethoxy-N-(4-phenoxyphenyl)quinazolin-4-amine
- 現地名
- 6,7-ジメトキシ-N-(4-フェノキシフェニル)-4-キナゾリンアミン
- 英語名
- 6,7-Dimethoxy-N-(4-phenoxyphenyl)-
- 分子式
- C22H19N3O3
- 分子量
- 373.41
名称と別名
名称をさらに表示
データベース識別子
- CAS
179248-59-0- PubChem CID
- 1474853
- DTXSID
DTXSID50363056- ChEMBL
CHEMBL97771- ChEBI
CHEBI:78332- EC Number
- 686-974-3
- Nikkaji
- J1.446.049G
物性
構造計算による物性
- XLogP
- 4.9
- 極性表面積
- 65.5 Ų
- 水素結合供与体数
- 1
- 水素結合受容体数
- 6
- 回転可能結合数
- 6
- 重原子数
- 28
- 形式電荷
- 0
- 複雑度
- 466
物理化学的性質
- 沸点
- 528.151 · 528.151±50.00 °C(Press: 760.00 Torr)(predicted)
- 比重(密度)
- 1.267 · 1.267±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
- 貯蔵温度
- 2 · 2-8°C
- 溶解性
- 10 mg/mL · DMSO:>10mg/mL
- 外見
- 白い粉
- 酸解離定数(Pka)
- 6.753 · 6.753±0.30(predicted)
- 色
- 白またはオフホワイト
- 由来生物
- rabbit
- 安定性
- 2 · 購入日から2年間安定です。この DMSO 溶液は、-20°C で 1 週間保存できます。
- InChI
- 1S/C22H19N3O3/c1-26-20-12-18-19(13-21(20)27-2)23-14-24-22(18)25-15-8-10-17(11-9-15)28-16-6-4-3-5-7-16/h3-14H,1-2H3,(H,23,24,25)
- InChIKey
- DMWVGXGXHPOEPT-UHFFFAOYSA-N
- SMILES
- COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC
安全と法規制
GHS分類
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
危険有害性情報
安全データ
- wgk
- 3
- ridadr
- UN 3077 9 / PGIII
- risk_code
- 22-36/37/38
- hazard_code
- Xn
- safety_code
- 26
- ストレージクラス
- 11 - Combustible Solids
化学と産業
応用分野
使用Src Kinase inhibitor 1 lung cancers with EGF receptor abnormalities and is a potential candidate for mol.-targeted therapy
一般的な説明A potent, selective, dual site, cell-permeable, reversible and ATP-competitive inhibitor of Src tyrosine kinase (IC50 = 44 nM and 88 nM for Src and Lck, respectively). Shown to simultaneously interact with both the ATP- and peptide-binding sites. Inhibits VEGFR2 and c-fms tyrosine kinases only at higher concentrations (IC50 = 320 nM and 30 μM, respectively).
サプライヤー67 社
関連反応
現在のフィルター条件では反応記録がありません。
化合物ノート
読み込み中…